Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial ribosomal protein 63 pseudogene (ENSG00000262561) is a genomic DNA segment in humans that resembles the sequence of the functional mitochondrial ribosomal protein 63 gene but does not encode a functional protein product. Pseudogenes like this arise from gene duplication or retrotransposition events and accumulate disabling mutations (e.g., premature stop codons, frameshifts). Most mitochondrial ribosomal protein (MRP) pseudogenes are processed or duplicated fragments scattered throughout the genome, and while some pseudogenes may play regulatory roles by acting as decoys for microRNAs or generating noncoding RNAs, there is no evidence for such functions for this specific pseudogene[1][2][3]. It is not a receptor, enzyme, or transporter, and accordingly, is not considered a drug target nor associated with human disease or therapy.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein 63 pseudogene (None).